Woodmont Investment Counsel LLC lessened its position in Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) by 88.1% in the second quarter, according to its most recent disclosure with the SEC. The firm owned 2,200 shares of the company's stock after selling 16,351 shares during the period. Woodmont Investment Counsel LLC's holdings in Addus HomeCare were worth $253,000 as of its most recent filing with the SEC.
A number of other institutional investors also recently modified their holdings of the company. WCM Investment Management LLC lifted its holdings in shares of Addus HomeCare by 4.9% in the 1st quarter. WCM Investment Management LLC now owns 494,791 shares of the company's stock worth $48,143,000 after purchasing an additional 23,176 shares in the last quarter. Principal Financial Group Inc. raised its holdings in Addus HomeCare by 18.3% during the first quarter. Principal Financial Group Inc. now owns 475,818 shares of the company's stock worth $47,054,000 after buying an additional 73,720 shares during the last quarter. Wellington Management Group LLP lifted its stake in shares of Addus HomeCare by 25.8% in the first quarter. Wellington Management Group LLP now owns 471,935 shares of the company's stock valued at $46,670,000 after buying an additional 96,823 shares in the last quarter. Invesco Ltd. grew its holdings in shares of Addus HomeCare by 19.8% during the first quarter. Invesco Ltd. now owns 414,705 shares of the company's stock valued at $41,010,000 after buying an additional 68,585 shares during the last quarter. Finally, Northern Trust Corp increased its position in shares of Addus HomeCare by 6.7% during the first quarter. Northern Trust Corp now owns 305,109 shares of the company's stock worth $30,172,000 after acquiring an additional 19,237 shares in the last quarter. 95.35% of the stock is owned by institutional investors and hedge funds.
Addus HomeCare Trading Down 1.9%
Shares of ADUS stock opened at $112.70 on Tuesday. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.17. The firm has a market cap of $2.08 billion, a P/E ratio of 24.88, a PEG ratio of 1.75 and a beta of 0.86. The company has a 50 day moving average of $113.19 and a 200-day moving average of $109.58. Addus HomeCare Corporation has a 12-month low of $88.96 and a 12-month high of $136.72.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its quarterly earnings data on Monday, August 4th. The company reported $1.49 earnings per share for the quarter, beating the consensus estimate of $1.45 by $0.04. The business had revenue of $349.44 million during the quarter, compared to analyst estimates of $345.71 million. Addus HomeCare had a return on equity of 9.39% and a net margin of 6.51%.Addus HomeCare's revenue was up 21.8% compared to the same quarter last year. During the same period in the prior year, the company earned $1.35 earnings per share. Sell-side analysts anticipate that Addus HomeCare Corporation will post 4.59 earnings per share for the current year.
Insider Buying and Selling
In other news, EVP Brian Poff sold 7,739 shares of Addus HomeCare stock in a transaction dated Monday, August 25th. The shares were sold at an average price of $116.82, for a total value of $904,069.98. Following the completion of the transaction, the executive vice president owned 56,980 shares in the company, valued at $6,656,403.60. This trade represents a 11.96% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Veronica Hill-Milbourne sold 1,571 shares of the business's stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $114.93, for a total transaction of $180,555.03. Following the completion of the sale, the director directly owned 5,067 shares in the company, valued at approximately $582,350.31. This trade represents a 23.67% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 34,310 shares of company stock valued at $3,958,375. 4.50% of the stock is owned by insiders.
Analyst Upgrades and Downgrades
ADUS has been the subject of a number of analyst reports. Weiss Ratings reiterated a "hold (c+)" rating on shares of Addus HomeCare in a research note on Saturday, September 27th. Royal Bank Of Canada lifted their target price on Addus HomeCare from $133.00 to $134.00 and gave the company an "outperform" rating in a research report on Friday, August 22nd. Stephens reiterated an "overweight" rating and issued a $140.00 target price on shares of Addus HomeCare in a research note on Wednesday, September 3rd. TD Cowen upped their target price on Addus HomeCare from $135.00 to $139.00 and gave the company a "buy" rating in a report on Wednesday, August 6th. Finally, UBS Group began coverage on Addus HomeCare in a research report on Tuesday, September 2nd. They set a "buy" rating and a $145.00 price target for the company. Two research analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, Addus HomeCare currently has an average rating of "Moderate Buy" and an average target price of $138.89.
View Our Latest Analysis on ADUS
About Addus HomeCare
(
Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.